Related Experiment Videos
[Laurence-Moon-Bardet-Biedl syndrome]
B Lofterød1, R Riise, T Skuseth
1Sentralsykehuset for Ostfold, Fredrikstad.
Nordisk Medicin
|January 1, 1990
Summary
Laurence-Moon-Biedl syndrome (LMBB) affects 1 in 128,000 individuals in Norway. Cardinal signs include vision loss, obesity, and extra fingers/toes, with most patients exhibiting normal intelligence.
Area of Science:
- Genetics and rare diseases
- Ophthalmology
- Pediatrics
Context:
- A 1984 Norwegian registry identified 32 individuals with Laurence-Moon-Bardet-Biedl syndrome (LMBB).
- The prevalence rate was determined to be 1 in 128,000 inhabitants.
- A multidisciplinary team at Frambu Health Centre provided comprehensive care to 26 patients.
Purpose:
- To document the prevalence and clinical manifestations of Laurence-Moon-Bardet-Biedl syndrome in Norway.
- To assess the cardinal signs and associated features of LMBB.
- To investigate the cognitive status of individuals with LMBB, challenging the assumption of universal intellectual disability.
Summary:
- The study identified 32 cases of Laurence-Moon-Bardet-Biedl syndrome (LMBB) in Norway, with a prevalence of 1 in 128,000.
- Key clinical features observed were retinitis pigmentosa, obesity, polydactyly, and dental anomalies, with hypogenitalism noted in many.
- Contrary to common belief, most patients appeared to have normal intelligence, warranting further investigation.
Impact:
- Provides crucial epidemiological data on Laurence-Moon-Bardet-Biedl syndrome in a specific population.
- Highlights the importance of a multidisciplinary approach in managing rare genetic disorders.
- Challenges existing perceptions regarding cognitive impairment in LMBB, suggesting a need for re-evaluation.